| Dr Teresa Elizabeth Frazer, MD | |
|
510 Cherry St, Suite #201, Bluefield, WV 24701-3338 | |
| (304) 327-1630 | |
| (304) 327-1660 |
| Full Name | Dr Teresa Elizabeth Frazer |
|---|---|
| Gender | Female |
| Speciality | Pediatrics - Pediatric Endocrinology |
| Location | 510 Cherry St, Bluefield, West Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235237405 | NPI | - | NPPES |
| 010119294 | Medicaid | VA | |
| 1808202000 | Medicaid | WV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080P0205X | Pediatrics - Pediatric Endocrinology | 19621 (West Virginia) | Primary |
| Entity Name | Princeton Community Hospital Assn. Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093917643 PECOS PAC ID: 3678482221 Enrollment ID: O20031211000436 |
News Archive
Adelaide researchers have taken a step closer to the development of a universal flu vaccine, with results of a recent study showing that a vaccine delivered by a simple nasal spray could provide protection against influenza.
Some drug manufacturers are aggressively pushing legislative proposals in states across the country that if enacted would undermine electronic prescribing's (e-prescribing) proven safety and savings benefits, the Pharmaceutical Care Management Association (PCMA) said today.
Biomerica, Inc. (OTCBB: BMRA), a global provider of advanced diagnostic products for the early detection of medical conditions, today reported net sales for the fiscal year 2009 were $4,934,771 versus net sales of $4,926,505 in fiscal 2008.
Ocular Therapeutix™, Inc., a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, has announced the resubmission of the Company's New Drug Application to the U.S. Food and Drug Administration for its lead product candidate DEXTENZA™ 0.4mg, for the treatment of ocular pain following ophthalmic surgery.
The list is long. From the common cold and influenza to HIV and measles, and from Zika to some cancers, all are caused by viruses — tiny packages of either DNA or RNA that wear a protein coat.
› Verified 5 days ago
| Entity Name | Reynolds Memorial Hospital, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518068014 PECOS PAC ID: 9830184530 Enrollment ID: O20040420000896 |
News Archive
Adelaide researchers have taken a step closer to the development of a universal flu vaccine, with results of a recent study showing that a vaccine delivered by a simple nasal spray could provide protection against influenza.
Some drug manufacturers are aggressively pushing legislative proposals in states across the country that if enacted would undermine electronic prescribing's (e-prescribing) proven safety and savings benefits, the Pharmaceutical Care Management Association (PCMA) said today.
Biomerica, Inc. (OTCBB: BMRA), a global provider of advanced diagnostic products for the early detection of medical conditions, today reported net sales for the fiscal year 2009 were $4,934,771 versus net sales of $4,926,505 in fiscal 2008.
Ocular Therapeutix™, Inc., a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, has announced the resubmission of the Company's New Drug Application to the U.S. Food and Drug Administration for its lead product candidate DEXTENZA™ 0.4mg, for the treatment of ocular pain following ophthalmic surgery.
The list is long. From the common cold and influenza to HIV and measles, and from Zika to some cancers, all are caused by viruses — tiny packages of either DNA or RNA that wear a protein coat.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Teresa Elizabeth Frazer, MD 1320 Maplewood Ave, Suite #201, Ronceverte, WV 24970-8016 Ph: (304) 647-4411 | Dr Teresa Elizabeth Frazer, MD 510 Cherry St, Suite #201, Bluefield, WV 24701-3338 Ph: (304) 327-1630 |
News Archive
Adelaide researchers have taken a step closer to the development of a universal flu vaccine, with results of a recent study showing that a vaccine delivered by a simple nasal spray could provide protection against influenza.
Some drug manufacturers are aggressively pushing legislative proposals in states across the country that if enacted would undermine electronic prescribing's (e-prescribing) proven safety and savings benefits, the Pharmaceutical Care Management Association (PCMA) said today.
Biomerica, Inc. (OTCBB: BMRA), a global provider of advanced diagnostic products for the early detection of medical conditions, today reported net sales for the fiscal year 2009 were $4,934,771 versus net sales of $4,926,505 in fiscal 2008.
Ocular Therapeutix™, Inc., a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, has announced the resubmission of the Company's New Drug Application to the U.S. Food and Drug Administration for its lead product candidate DEXTENZA™ 0.4mg, for the treatment of ocular pain following ophthalmic surgery.
The list is long. From the common cold and influenza to HIV and measles, and from Zika to some cancers, all are caused by viruses — tiny packages of either DNA or RNA that wear a protein coat.
› Verified 5 days ago
Dana Fawzi Ghishan, M.D Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 500 Cherry St, Bluefield, WV 24701 Phone: 304-327-1100 |